Example 10
Mouse Immunization
Female C57BL/6 mice (Taconic Farms) were used at 6 to 8 weeks of age, and food and water were provided ad libitum. All animal procedures were in accordance with government and institutional guidelines for animal health and well-being, and were approved by the Merck Institutional Animal Care and Use Committee.
Animals were immunized by subcutaneous (s.c.) routes with rMOMP (1 to 10 μg/mouse/immunization) in combination with an adjuvant containing IMO-2055 and Montanide ISA 720 VG (SEPPIC Inc., Coley Pharmaceutical Group Inc., Wellesley, Mass.) at a ratio of 70:30 (v/v). Live EB groups were immunized with 1×106 EB in SPG per mouse by intraperitoneal (i.p.) route. Adjuvant control groups were administered with a combination of IMO-2055 and Montanide ISA 720 VG only. Immunizations were administered on days 0, 20 and 30.
Prior to the first immunization and two weeks following the final immunization, tail bleeds were performed with blood collected in BD Microtainer® Serum Separator Tubes (Becton, Dickinson and Company, Franklin Lakes, N.J.). Blood samples were centrifuged at 6,000 rpm for 5 min and serum was transferred to a microcentrifuge tube.